4//SEC Filing
BINUR YUVAL 4
Accession 0001209191-04-020333
CIK 0001062216other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:58 PM ET
Size
38.3 KB
Accession
0001209191-04-020333
Insider Transaction Report
Form 4
GELLER EHUD
Other
Transactions
- Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote)
Transactions
- Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying)
BINUR YUVAL
Other
Transactions
- Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying)
Transactions
- Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote)
Transactions
- Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote)
Transactions
- Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote)
Transactions
- Conversion
Common Stock
2004-04-08+113,161→ 113,161 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+82,481→ 82,481 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−594,140→ 0 total(indirect: See Footnote)→ Common Stock (198,046 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−247,442→ 0 total(indirect: See Footnote)→ Common Stock (82,481 underlying) - Conversion
Common Stock
2004-04-08+198,046→ 198,046 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+29,550→ 29,550 total(indirect: See Footnote) - Conversion
Common Stock
2004-04-08+157,287→ 157,287 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−442,000→ 0 total(indirect: See Footnote)→ Common Stock (157,287 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−88,651→ 0 total(indirect: See Footnote)→ Common Stock (29,550 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−318,000→ 0 total(indirect: See Footnote)→ Common Stock (113,161 underlying)
Footnotes (9)
- [F1]The shares of Series C Convertible Preferred Stock reported are owned by Medica II Investments (International) LP. Dr. Yuval Binur and Dr. Ehud Geller are each 50% holders of Medica II Investments GP Co., Ltd., which is the general partner of Medica II Management L.P., which in turn is the general partner of Medica II Investments (International) LP. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]The shares of Series C Convertible Preferred Stock reported are owned by Medica II Investments (Israel) LP. Dr. Yuval Binur and Dr. Ehud Geller are each 50% holders of Medica II Investments GP Co., Ltd., which is the general partner of Medica II Management L.P., which in turn is the general partner of Medica II Investments (International) LP. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F3]The shares of Series D Convertible Preferred Stock reported are owned by Medica II Investments (International) LP. Dr. Yuval Binur and Dr. Ehud Geller are each 50% holders of Medica II Investments GP Co., Ltd., which is the general partner of Medica II Management L.P., which in turn is the general partner of Medica II Investments (International) LP. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F4]The shares of Series D Convertible Preferred Stock reported are owned by Medica II Investments (Israel) LP. Dr. Yuval Binur and Dr. Ehud Geller are each 50%holders of Medica II Investments GP Co., Ltd., which is the general partner of Medica II Management L.P., which in turn is the general partner of Medica II Investments (International) LP. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F5]The shares of Series D Convertible Preferred Stock reported are owned by Medica II Investments (P.F.) (Israel) LP. Dr. Yuval Binur and Dr. Ehud Geller are each 50% holders of Medica II Investments GP Co., Ltd., which is the general partner of Medica II Management L.P., which in turn is the general partner of Medica II Investments (International) LP. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F6]Each share of Series C Convertible Preferred Stock converted into .3559 shares of Common Stock.
- [F7]These securities automatically converted into Common Stock upon the closing of the issuer?s initial public offering.
- [F8]These securities do not have an expiration date.
- [F9]Each share of Series D Convertible Preferred Stock converted into .3333 shares of Common Stock.
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001284385
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:58 PM ET
- Size
- 38.3 KB